Helix Biopharma Corporation is a biotechnology company focused on developing innovative therapies for the treatment of cancer. The organization specializes in the research and development of proprietary drug candidates, particularly in the area of immunotherapy, which aims to harness the body's immune system to combat cancerous cells. Based in Aurora, California, Helix Biopharma is dedicated to advancing its pipeline of therapeutic solutions, leveraging cutting-edge technology to address unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#10 in Aurora

#1,067 in Canada

#42,249 in the World

Aurora, Canada

Helix Biopharma Corporation

Forward Citations = 218

19 inventors:

Wah Yau Wong (9 out of 14 patents)

Heman Chao (6 out of 6 patents)

Baomin Tian (5 out of 6 patents)

4. Praveen Kumar (5 out of 6 patents)

5. Marni Diane Uger (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Helix Biopharma Corporation. Retrieved from https://idiyas.com/company/helix-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]